文献速递显微修复重建乳房整形与再造

术中选择性使用升压药与DIEP皮瓣并发症风险增加无关

Selective Intraoperative Vasopressor Use Is Not Associated with Increased Risk of DIEP Flap Complications.
PubMed 文献 · Plast Reconstr Surg · 2017-01-01

该研究回顾性分析单中心3年内333例患者共475例DIEP皮瓣手术,采用单变量分析控制混杂因素。结果显示麻黄碱与术中皮瓣并发症风险降低显著相关(OR 0.88),去氧肾上腺素无显著关联,升压药使用未增加60天内坏死再手术风险。

要点

  • 麻黄碱与DIEP皮瓣术中并发症风险降低相关(OR 0.88)。
  • 去氧肾上腺素与并发症率无显著关联。
  • 升压药未增加60天内坏死再手术风险。

核心结论

  • DIEP皮瓣术中因低血压使用麻黄碱与术中皮瓣并发症率降低相关,去氧肾上腺素无显著关联。
  • 常规完全避免升压药以担忧恶化DIEP皮瓣结局的做法不被本研究支持。

研究设计与样本

  • 回顾性综述单中心3年内475例连续DIEP皮瓣病例(333例患者),采用单变量分析处理潜在混杂因素。
  • 证据等级:治疗性,III级。

主要发现

  • 控制低血压严重程度和持续时间后,麻黄碱使用与术中皮瓣并发症(包括需修整的血管痉挛、血栓和淤血)风险降低显著相关(OR 0.88)。
  • 去氧肾上腺素与并发症率无显著关联。
  • 升压药使用与60天内坏死情况下再手术风险增加无关。

关键数值与推荐

  • 麻黄碱与术中皮瓣并发症风险降低相关:OR 0.88。
  • 去氧肾上腺素与并发症率无显著关联。

临床怎么用

  • DIEP皮瓣术中低血压时可考虑选择性使用麻黄碱,而非完全禁用升压药。
  • 去氧肾上腺素对DIEP皮瓣并发症无显著影响,但需结合临床情况使用。

局限性

  • 单中心回顾性设计,仅采用单变量分析,可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During deep inferior epigastric perforator (DIEP) flap cases, anesthesiologists commonly avoid intravenous vasopressor administration because of the theoretical concern of inducing vasospasm, thrombosis, or congestion in the vessels of the anastomosis, potentially resulting in poor flap perfusion and ischemia and necessitating revision. In the setting of hypotension, however, vasopressor administration may actually improve outcomes by augmenting flap perfusion by means of increased mean arterial pressure. METHODS: The authors reviewed 475 consecutive DIEP flap cases in 333 patients at a single large academic medical center over a 3-year period, addressing potential confounders using univariate analyses. RESULTS: Ephedrine administration was significantly associated with decreased risk of intraoperative flap complications (OR, 0.88), including vasospasm, thrombosis, and congestion requiring revision, compared with controls, after controlling for the severity and duration of hypotension. Phenylephrine had no significant association with complication rates. Vasopressor administration was not associated with an increased risk of reoperation in the setting of necrosis within 60 days. CONCLUSIONS: Ephedrine treatment for hypotension during DIEP flap cases is associated with decreased intraoperative flap complication rates compared with controls who did not receive vasopressors, whereas phenylephrine has no significant association. The common clinical practice of complete abstinence from vasopressors out of concern for worsening DIEP flap outcomes is not supported by this study. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Szabo Eltorai A, Huang CC, Lu JT, et al. Selective Intraoperative Vasopressor Use Is Not Associated with Increased Risk of DIEP Flap Complications. Plast Reconstr Surg. 2017. PMID: 28654605. doi:10.1097/PRS.0000000000003444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。